Signature

  J. Paul Neeley    //   Projects    //   Process   //   Links   //   Info   //


   / / // /// ///// //////// ///////////// ///////////////////// /////////////////////////////////// /////////////////////////////////////////////////////// //////////////////////////////////////////////////////////////////////////////////////////...

Gaia Corporation

The year is 2023 and we are listening in on a presentation of a company representative explaining the work of Gaia Corporation. We learn about Gaia Corporation’s mission to act as stewards of the earth’s intellectual property, to promote and protect bio diversity, and to manage synthetic biological risk. We learn about their views and understanding of biological value, the symmetry of invention & evolution, and review a case study of a collaboration between a major corporation & Gaia where Gaia helped generate new value for through the licensing of an evolved genome as chassis that was genetically modified to create a new product. We learn about what the future holds for Gaia Corporation and discuss issues of DIY synthetic biology, new element & chemical product lines, and a movement towards total bio measurement. The presentation closes with questions from the audience about the work at Gaia Corporation and issues of synthetic biology.





Z33's Alter Nature: Designing Nature – Designing Human Life – Owning Life




// Z33's Alter Nature: Designing Nature – Designing Human Life – Owning Life
// Center for Synthetic Biology and Innovation at Imperial College London
// Challenges in Top-Down, Bottom-Up and Computational Approaches in Synthetic Biology, a SynBioNT Symposium
// Design Indaba


// Gaia Corporation Corporate Website
// Twitter

Special Thanks // Fiona Raby / James King / Daisy Ginsberg






  / / // /// ///// //////// ///////////// ///////////////////// /////////////////////////////////// /////////////////////////////////////////////////////// //////////////////////////////////////////////////////////////////////////////////////////...

  © 2103 J. Paul Neeley